Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Industry News

Related Searches:

Filter by:

January 12, 2012
Adds Brabender equipment   Read More »
January 11, 2012
Will provide clinical materials, support to ImmusanT   Read More »
January 11, 2012
Alliance provides customers with enhanced EP products portfolio   Read More »
January 9, 2012
PE owners sell for $350 million   Read More »
January 9, 2012
Gains Phase II HCV drug in $2.5 billion purchase   Read More »
January 9, 2012
Quality problems lead to shutdown, recalls, $120 million charge, group-wide review   Read More »
January 9, 2012
Trial restarts with replacement material   Read More »
January 6, 2012
Plans to outsource large-scale manufacturing, research   Read More »
January 6, 2012
Combines product and lab support services for customers   Read More »
January 6, 2012
Pays $25 million for worldwide development and commercialization license   Read More »
January 5, 2012
Recommended best practices address challenges posed by globalization   Read More »
January 3, 2012
New computational module models elution of API   Read More »
December 27, 2011
Quality issues to derail sterile injectables till 4Q12   Read More »
December 22, 2011
New initiative expected to bring annual savings to $10 million   Read More »
December 22, 2011
Healthcare group buys Israeli HPAPI maker   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On